Dawn Parsell Selected Research

veverimer

1/2021	Assessment of the Potential for Veverimer Drug-Drug Interactions.
4/2019	Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
1/2019	Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension.
1/2018	Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dawn Parsell Research Topics

Disease

4	Acidosis 01/2021 - 01/2018
3	Chronic Renal Insufficiency 01/2021 - 01/2019
1	Hypoplastic Left Heart Syndrome 01/2021
1	Bone Resorption 04/2019
1	Constipation 04/2019
1	Flatulence 04/2019
1	Nausea 04/2019
1	Disease Progression 04/2019
1	Kidney Diseases (Kidney Disease) 01/2019
1	Hypertension (High Blood Pressure) 01/2018
1	Heart Failure 01/2018
1	Inflammation (Inflammations) 01/2018

Drug/Important Bio-Agent (IBA)

4	veverimerIBA 01/2021 - 01/2018
3	Bicarbonates (Hydrogen Carbonate)IBA 04/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2021 - 04/2019
2	Hydrochloric Acid (Hydrogen Chloride)FDA Link 04/2019 - 01/2018
1	PolymersIBA 01/2021
1	AcidsIBA 04/2019
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 04/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	SuspensionsIBA 01/2019
1	SodiumIBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018

Therapy/Procedure

1	Transplantation 01/2021
1	Therapeutics 04/2019